Regeneron Pharmaceuticals, Inc. (REGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 688.26 |
| Open | 685.80 |
| Bid | 697.33 x 1300 |
| Ask | 699.00 x 900 |
| Day's Range | 681.00 - 699.35 |
| 52 Week Range | 538.01 - 754.67 |
| Volume | |
| Avg. Volume | 669,855 |
| Market Cap | 74.993B |
| Beta (5Y Monthly) | 0.31 |
| PE Ratio (TTM) | 22.85 |
| EPS (TTM) | 30.52 |
| Earnings Date | Feb 03, 2022 - Feb 07, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 685.14 |
- Simply Wall St.
Possible bearish signals as Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) insiders disposed of US$16m worth of stock
In the last year, many Regeneron Pharmaceuticals, Inc. ( NASDAQ:REGN ) insiders sold a substantial stake in the company...
- Simply Wall St.
Are Strong Financial Prospects The Force That Is Driving The Momentum In Regeneron Pharmaceuticals, Inc.'s NASDAQ:REGN) Stock?
Regeneron Pharmaceuticals' (NASDAQ:REGN) stock is up by a considerable 22% over the past three months. Since the market...
- Zacks
Regeneron (REGN)/ Alnylam Report Promising Data from NASH Study
Regeneron (REGN) and its partner Alnylam announce promising data from its ongoing phase I study evaluating ALN-HSD in healthy adults and NASH patients.
© 2022 Yahoo. All rights reserved.
